RPG Life Sciences Limited (NSE:RPGLIFE)
2,141.70
-27.50 (-1.27%)
Jun 6, 2025, 3:29 PM IST
RPG Life Sciences Revenue
In the fiscal year ending March 31, 2025, RPG Life Sciences had annual revenue of 6.53B INR with 12.26% growth. RPG Life Sciences had revenue of 1.43B in the quarter ending March 31, 2025, with 12.68% growth.
Revenue
6.53B
Revenue Growth
+12.26%
P/S Ratio
5.42
Revenue / Employee
5.15M
Employees
1,270
Market Cap
35.42B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 6.53B | 713.80M | 12.26% |
Mar 31, 2024 | 5.82B | 692.40M | 13.50% |
Mar 31, 2023 | 5.13B | 726.50M | 16.51% |
Mar 31, 2022 | 4.40B | 510.20M | 13.11% |
Mar 31, 2021 | 3.89B | 135.70M | 3.61% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 271.45B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 122.07B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 129.65B |
RPG Life Sciences News
- 5 weeks ago - RPG Life Sciences shares surge nearly 8% after Q4 net profit jumps 786% on one-time land gain - Business Upturn
- 4 months ago - RPG Life Sciences surges 9.36% on robust Q3 FY25 earnings; net profit up 32% YoY - Business Upturn
- 4 months ago - Stocks in focus today, January 27, 2025: JK Cement, Balkrishna Industries, Shakti Pumps, Yes Bank, KEC International, Trident, RPG Life Sciences, Jubilant Pharmova - Business Upturn
- 5 months ago - RPG Life Sciences reports fire incident at manufacturing plant in Navi Mumbai - Business Upturn